Menu Close
  • Home
    •

Stay informed on the latest in arthritis prevention, research, treatment and care with JointHealth™ express, Canada's trusted source for arthritis news. Delivered right to your inbox, this "breaking news" bulletin provides timely updates on key arthritis topics, including disease management, research breakthroughs, and treatment advancements. As the longest-running arthritis news source in Canada, JointHealth™ express provides you expert insights from patients and analysis from arthritis health care professionals to help you on your arthritis journey. Stay connected to the arthritis information that matters most.

Click here to see JointHealth™ express bulletins from 2023 and earlier.

Latest News

Arthritis At Home 312 – National Survey on Lupus Report Highlights

In this episode of Arthritis At Home, we speak with Dr. Stephanie Keeling about the results of the National ...
Read More

JointHealth™ insight – National Survey on Lupus Report: Part One

In a special edition of JointHealthTM insight, Arthritis Consumer Experts reports on the findings from an online survey, co-developed ...
Read More

Do you live with chronic pain? Researchers at Western University want to hear from you!

Researchers at Western University through the Partnership for the Engagement of People in Pain Research (PEPR https://www.pepr-partnership.org) are currently ...
Read More

Arthritis At Home 311 – Advanced physiotherapist practitioner in juvenile idiopathic arthritis care

In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Ms. Julie Herrington, an Advanced ...
Read More

New blog post from Joint Journeys, life with arthritis by Carrie: The sum of it all

In her latest blog, Carrie highlights how when you add up all the little things, it becomes something quite ...
Read More

Let BC PharmaCare hear Your Voice on sarilumab (Kevzara®) for the treatment of polymyalgia rheumatica in adults

Sarilumab (Kevzara®) is now being considered for coverage under the British Columbia Ministry of Health’s PharmaCare program. By filling out ...
Read More

Arthritis At Home 310 – Patients and patents: Understanding how pharmaceutical patents affect medication cost

In this episode of Arthritis at Home, we explore an issue that affects every person who relies on medication ...
Read More

“Patients and patents” campaign partners launch website

Prescription drug prices continue to rise around the world, putting essential medications out of reach for too many people ...
Read More

Arthritis at Home 309 – A conversation on arthritis and mental health

What does mental health really look like when you are living with arthritis? In a new episode of Arthritis ...
Read More

Now Launching: JointHealth™ Education – Arthritis and Mental Health

Arthritis affects more than joints. It affects sleep. Energy. Confidence. Relationships. Work. And for many people, it affects mental ...
Read More

Arthritis At Home 308 – Blind studies and therapeutic effects in scleroderma

In this episode of Arthritis At Home, we are featuring the #CRArthritis with Dr. Inés Colmegna, clinician-scientist in the ...
Read More

Reminder: Call for patient input on anifrolumab (Saphnelo®) for systemic lupus erythematosus

Canada’s Drug Agency (CDA-AMC) is currently welcoming patients and their caregivers to provide input to patient organizations on the manufacturer’s ...
Read More